Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 18, 2026 | BlueCross BlueShield of Tennessee | Romidepsin [Istodax; Romidepsin (liquid)] | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Valoctocogene Roxaparvovec‐rvox (Roctavian) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Oncology Indications) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Non-Oncology Indications) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Rituximab and Hyaluronidase Human Injection (Rituxan Hycela) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Risankizumab-rzaa (Skyrizi) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Retinal Telescreening for Diabetic Retinopathy | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Retifanlimab-dlwr (Zynyz) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Ravulizumab-cwvz (Ultomiris) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Ranibizumab (Susvimo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Ranibizumab (Lucentis, Byooviz; Cimerli) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Sipuleucel-T (Provenge) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Prostate Specific Antigen (PSA) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Prademagene Zamikeracel (Zevaskyn) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Pozelimab-bbfg (Veopoz) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Polatuzumab Vedotin-piiq (Polivy) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Plasminogen, human-tvmh (Ryplazim) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Pertuzumab, Trastuzumab and Hyaluronidase-zzxf (Phesgo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Pertuzumab (Perjeta); Pertuzumab-dpzb (Poherdy) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Pegcetacoplan (Syfovre) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Sodium Thiosulfate (Pedmark) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Pasireotide (Signifor LAR) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Zopapogene Imadenovec-drba (Papzimeos) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Panitumumab (Vectibix) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Palivizumab (Synagis) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Lumasiran (Oxlumo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Osteochondral Autografting | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Patisiran Lipid Complex (Onpattro) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Pegaspargase (Oncaspar) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Olipudase Alfa-rpcp (Xenpozyme) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Pegfilgrastim (Neulasta); Pegfilgrastim-jmdb (Fulphila); Pegfilgrastim--pbbk (Fylnetra); Pegfilgrastim- apgf (Nyvepria); Pegfilgrastim-fpgk (Stimufed); Pegfilgrastim-cbqv (Udenyca); Pegfilgrastim-bmez (Ziextenzo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Romiplostim(Nplate) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Nivolumab/Relatlimab-rmbw (Opdualag) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Nedosiran (Rivfloza) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Necitumumab (Portrazza) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Natalizumab (Tysabri), Natalizumab-sztn (Tyruko) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Multiple Sclerosis Products:(Ocrelizumab [Ocrevus], Ocrelizumab and Hyaluronidase-ocsq [Ocrevus Zunovo], Ublituximab-xiiy [Briumvi]) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Tafasitamab-cxix (Monjuvi) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Mogamulizumab-kpkc (Poteligeo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Mirikizumab-mrkz (Omvoh) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Microwave Ablation for Oncologic Tumors | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Vestronidase Alfa-vjbk(Mepsevii) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Mepolizumab (Nucala) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Mastectomy for Gynecomastia | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | FDA-Approved Indications | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Voretigene Neparvovec-rzyl (Luxturna) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Luspatercept-aamt (Reblozyl) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Mosunetuzumab-axgb (Lunsumio, Lunsumio Velo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Lovotibeglogene Autotemcel (Lyfgenia) | Criteria changed |